Citations

Clear

7732 citation(s) found for "Ma, Daniel".

An Endocrinologist-Supported Intervention Aimed at Providers Improves Diabetes Management in a Primary Care Site
Ziemer, David C., Doyle, Joyce , Barnes, Catherine S., Kolm, Paul , Branch, William T. , Caudle, J., Dunbar, Virginia G., El‐Kebbi, Imad M., Gallina, Daniel L., Hayes, Risa P., Miller, Christopher D. , Rhee, Mary K. , Thompson, Dennis M., Watkins, Clyde, Phillips, Lawrence S. , Cook, Curtiss B.

Mayo Clinic

Diabetes Care | March 5, 2007 | Volume: 28 | Issue: 10 | Pages: 2352-2360

10.2337/diacare.28.10.2352 | PMID 16186262 Get It

OBJECTIVE—Management of diabetes is frequently suboptimal in primary care settings, where providers often fail to intensify therapy when glucose levels are high, a problem known as clinical inertia. We asked whether interventions targeting clinical inertia can improve outcomes. RESEARCH DESIGN AND METHODS—A controlled trial over a 3-year period was conducted in a municipal hospital primary care clinic in a large academic medical center. We studied all patients (4,138) with type 2 diabetes who were seen in continuity clinics by 345 internal medicine residents and were randomized to be control subjects or to receive one of three interventions. Instead of consultative advice, the interventions were hard copy computerized reminders that provided patient-specific recommendations for management at the time of each patient’s visit, individual face-to-face feedback on performance for 5 min every 2 weeks, or both. RESULTS—Over an average patient follow-up of 15 months within the intervention site, improvements in and final HbA1c (A1C) with feedback + reminders (ΔA1C 0.6%, final A1C 7.46%) were significantly better than control (ΔA1C 0.2%, final A1C 7.84%, P < 0.02); changes were smaller with feedback only and reminders only (P = NS vs. control). Trends were similar but not significant with systolic blood pressure (sBP) and LDL cholesterol. Multivariable analysis showed that the feedback intervention independently facilitated attainment of American Diabetes Association goals for both A1C and sBP. Over a 2-year period, overall glycemic control improved in the intervention site but did not change in other primary care sites (final A1C 7.5 vs. 8.2%, P < 0.001). CONCLUSIONS—Feedback on performance aimed at overcoming clinical inertia and given to internal medicine resident primary care providers improves glycemic control. Partnering generalists with diabetes specialists may be important to enhance diabetes management in other primary care settings.
Radical pancreatoduodenectomy for misdiagnosed pancreatic mass
Smith, C. Daniel , Behrns, K.E. , Heerden, Jonathan A. van, Sarr, M. G.

Mayo Clinic

Journal of British Surgery | March 3, 2007 | Volume: 81 | Issue: 4 | Pages: 585-589

10.1002/bjs.1800810435 | PMID 7911387 Get It

Abstract Occasionally pancreatoduodenectomy is performed for clinically suspected pancreatic malignancy only for the surgeon to find that a benign aetiology accounts for the pancreatic mass. The aim of this study was twofold: to determine the incidence of pancreatoduodenectomy performed for a misdiagnosis of pancreatoduodenal malignancy and to identify potentially avoidable errors in preoperative and intraoperative judgement. Between 1956 and 1990, radical pancreatoduodenectomy was performed in 603 patients at the Mayo Clinic; 29 (5 per cent) underwent pancreatoduodenectomy for a diagnosis made before and during surgery of primary pancreatic or periampullary malignancy that was later proven histopathologically to be either unsuspected subacute or chronic pancreatitis (22 patients), benign fibrous common bile duct stricture (two), and penetrating duodenal ulcer, metastatic melanoma, ampullary adenoma, intrahepatic drug-induced cholestasis and pseudocyst (one each). No patient had a preoperative diagnosis of chronic pancreatitis. Weight loss, pain and/or jaundice were present in 27 of the 29 patients. Objective imaging tests, such as computed tomography, ultrasonography and/or endoscopic retrograde cholangio-pancreatography, were performed in 25 patients. Potential errors in judgement may be avoided by a more aggressive attempt at biopsy in selected patients; in others, resection for presumed malignancy may be unavoidable.
Fly the graying skies
Sirven, Joseph I , Morrow, Daniel

Mayo Clinic

Neurology | February 26, 2007 | Volume: 68 | Issue: 9 | Pages: 630-631

10.1212/01.wnl.0000257906.56206.31 | PMID 17325267 Get It

Tandem Transcorporal Artificial Urinary Sphincter Cuff Salvage Technique: Surgical Description and Results
Magera, James S., Elliott, Daniel S.

Mayo Clinic

Journal of Urology | February 11, 2007 | Volume: 177 | Issue: 3 | Pages: 1015-1020

10.1016/j.juro.2006.10.052 | PMID 17296400 Get It

Influenza virus targets the mRNA export machinery and the nuclear pore complex
Satterly, Neal, Tsai, Pei-Ling, Deursen, Jan van, Nussenzveig, Daniel R., Waziry, Paula A. Faria , Levay, Agata , Levy, David E. , Fontoura, Beatriz M. A. , Wang, Yaming

Mayo Clinic

Proceedings of the National Academy of Sciences | February 2, 2007 | Volume: 104 | Issue: 6 | Pages: 1853-1858

10.1073/pnas.0610977104 | PMID 17267598 Get It

The NS1 protein of influenza A virus is a major virulence factor that is essential for pathogenesis. NS1 functions to impair innate and adaptive immunity by inhibiting host signal transduction and gene expression, but its mechanisms of action remain to be fully elucidated. We show here that NS1 forms an inhibitory complex with NXF1/TAP, p15/NXT, Rae1/mrnp41, and E1B-AP5, which are key constituents of the mRNA export machinery that interact with both mRNAs and nucleoporins to direct mRNAs through the nuclear pore complex. Increased levels of NXF1, p15, or Rae1 revert the mRNA export blockage induced by NS1. Furthermore, influenza virus down-regulates Nup98, a nucleoporin that is a docking site for mRNA export factors. Reduced expression of these mRNA export factors renders cells highly permissive to influenza virus replication, demonstrating that proper levels of key constituents of the mRNA export machinery protect against influenza virus replication. Because Nup98 and Rae1 are induced by interferons, down-regulation of this pathway is likely a viral strategy to promote viral replication. These findings demonstrate previously undescribed influenza-mediated viral–host interactions and provide insights into potential molecular therapies that may interfere with influenza infection.
Innovations and Challenges in Renal Cell Carcinoma: Summary Statement from the Second Cambridge Conference
Figlin, Robert A. , George, Daniel J. , Kaelin, William G. , Kwon, Eugene D., Libermann, Towia A. , Pantuck, Allan J., Rosen, Mark, Sosman, Jeffrey A. , Sukhatme, Vikas P. , Vieweg, Johannes, Wood, Christopher G. , Atkins, Michael B. , Ernstoff, Marc S. , Flaherty, Keith T. , Linehan, William Marston , McDermott, David F. , Ochoa, Augusto C. , Rini, Brian I. , King, Laura

Mayo Clinic

Clinical Cancer Research | January 25, 2007 | Volume: 13 | Issue: 2 | Pages: 667s-670s

10.1158/1078-0432.ccr-06-2231 | PMID 17255291 Get It

Abstract Innovations and Challenges in Renal Cancer, chaired by Michael B. Atkins, was held April 28 to 29, 2006 in Cambridge, Massachusetts. The conference brought together leading experts in the fields of cancer research, medical oncology, urology, immunology, radiology, and immunotherapy, with the goal of advancing the field of renal cancer treatment by critiquing new data from ongoing clinical trials and stimulating communication among those involved in basic and clinical research. The conference proceedings published in this educational supplement to Clinical Cancer Research are intended to provide timely information and recommendations on important aspects of renal cancer genetics and biology and advances in prognostic classification and treatment.
Increased Adiposity Enhances Intrafollicular Estradiol Levels in Normoandrogenic Ovulatory Women Receiving Gonadotropin-Releasing Hormone Analog/Recombinant Human Follicle-Stimulating Hormone Therapy for in Vitro Fertilization
Dumesic, Daniel A. , Lesnick, Timothy G. , Abbott, David H.

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | January 24, 2007 | Volume: 92 | Issue: 4 | Pages: 1438-1441

10.1210/jc.2006-2161 | PMID 17244784 Get It

Abstract Context: Body mass index (BMI) reflects the amount of insulin in the human follicle and may enhance insulin action as a cogonadotropin. Objective: This study examined whether increased adiposity enhances intrafollicular steroidogenesis in normoandrogenic ovulatory women receiving GnRH analog/recombinant human FSH therapy for in vitro fertilization. Design, Setting, and Participants: Study participants were from an institutional practice and comprised 30 normoandrogenic ovulatory women who were lean (n = 17; BMI < 25 kg/m2) or overweight (n = 13; BMI ≥ 25 kg/m2). Women received GnRH analog after basal serum hormone determinations and oral glucose tolerance testing, followed by recombinant human FSH therapy and human chorionic gonadotropin administration when two or more follicles 18 mm or larger in diameter were present. Intervention: Follicle fluid was aspirated at oocyte retrieval from the first follicle of each ovary. Main Outcome Measures: Follicle fluid was assayed for estradiol (E2), progesterone, 17-hydroxyprogesterone, androstenedione, testosterone, dihydrotestosterone, insulin, glucose, and lactate. Results: Overweight women had hyperinsulinemia (P = 0.03) with decreased serum SHBG (P = 0.001) and increased serum free testosterone levels (P = 0.02). Elevated intrafollicular insulin levels in overweight women (P = 0.004) were accompanied by normal glucose and lactate levels. Intrafollicular E2 levels were greater in overweight vs. lean women (P = 0.03), whereas the remaining intrafollicular steroid levels were similar in both female groups. Conclusion: In normoandrogenic ovulatory women undergoing in vitro fertilization, increased adiposity elevates insulin and E2 levels in terminally differentiated follicles without altering intrafollicular androgen levels or luteinization. Additional studies are required to determine whether these abnormalities impair oocyte development.
Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia
Hunter, Christine , Dolimbek, Behzod Z., Dolimbek, Gulnoz S., Brashear, Allison , Comella, Cynthia , Gordon, Mark Forrest , Riley, David E., Singer, Carlos , Stacy, Mark, Tarsy, Daniel, Atassi, M. Zouhair, Jankovic, Joseph J. , Adler, Charles H. , Sethi, Kapil D.

Mayo Clinic

Neurology | December 26, 2006 | Volume: 67 | Issue: 12 | Pages: 2233-2235

10.1212/01.wnl.0000249308.66959.43 | PMID 17190952 Get It

Polyp Measurement with CT Colonography: Multiple-Reader, Multiple-Workstation Comparison
Young, Brett M., Paulsen, S, Booya, Fargol, Johnson, C. Daniel, Melton, Zackary, Rodysill, Drew, Mandrekar, Jay , Fletcher, Joel G. , Johnson, Kristina T.

Mayo Clinic

American Journal of Roentgenology | December 19, 2006 | Volume: 188 | Issue: 1 | Pages: 122-129

10.2214/ajr.05.1535 | PMID 17179354 Get It

Development of a Cathartic-Free Colorectal Cancer Screening Test Using Virtual Colonoscopy: A Feasibility Study
Carston, Michael J., Wentz, Robert J., Anderson, Steven M. , Johnson, C. Daniel, Johnson, Kristina T. , Manduca, Armando

Mayo Clinic

American Journal of Roentgenology | December 19, 2006 | Volume: 188 | Issue: 1 | Pages: W29-W36

10.2214/ajr.05.1484 | PMID 17179324 Get It